Boston Scientific (BSX) PT Raised to $110 at Truist Securities on Upside Potential
Tweet Send to a Friend
Truist Securities analyst Richard Newitter raised the price target on Boston Scientific (NYSE: BSX) to $110.00 (from $100.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
